SCHEMBL14601685

SCHEMBL14601685

O=S(=O)(Nc1ccc(C(F)(F)F)cc1)c1ccc(NS(=O)(=O)c2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.65
KMT2A Q03164 3/20 0.65
ALOX15 P16050 1/20 0.65
MAPK1 P28482 1/20 0.65
CA1 P00915 3/20 0.63
CA2 P00918 3/20 0.63
MAPT P10636 2/20 0.63
AR P10275 1/20 0.62
BRD4 O60885 1/20 0.61
HDAC3 O15379 1/20 0.61
HDAC4 P56524 1/20 0.61
HDAC1 Q13547 1/20 0.61
HDAC7 Q8WUI4 1/20 0.61
HDAC2 Q92769 1/20 0.61
HDAC10 Q969S8 1/20 0.61
HDAC11 Q96DB2 1/20 0.61
HDAC8 Q9BY41 1/20 0.61
HDAC6 Q9UBN7 1/20 0.61
HDAC9 Q9UKV0 1/20 0.61
HDAC5 Q9UQL6 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7577535 0.93 CA1 (0.65) MEN1KMT2AALOX15MAPK1CA1
SCHEMBL31198191 0.91 UQCRB (0.71) MEN1KMT2AALOX15MAPK1CA1
SCHEMBL95783 0.91 MEN1 (0.57) MEN1KMT2AALOX15MAPK1CA1
SCHEMBL29118836 0.91 KMT2A (0.71) MEN1KMT2AALOX15MAPK1CA1
SCHEMBL18031173 0.91 UQCRB (0.71) MEN1KMT2AALOX15MAPK1CA1
SCHEMBL7571036 0.91 CES1 (0.73) MEN1KMT2AALOX15MAPK1CA1
SCHEMBL4573249 0.91 KMT2A (0.71) MEN1KMT2AALOX15MAPK1CA1
SCHEMBL7572845 0.91 KMT2A (0.67) MEN1KMT2AALOX15MAPK1CA1
SCHEMBL2567685 0.91 NR1H3 (0.71) MEN1KMT2ACA1CA2MAPT
SCHEMBL12334076 0.88 RORA (0.78) MEN1KMT2AALOX15MAPK1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021509-A1 Phosphate transport inhibitors JOZEFIAK THOMAS H 2007-01-25 US disclosed
US-20070021509-A1 Phosphate transport inhibitors JOZEFIAK THOMAS H 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021509-A1 Phosphate transport inhibitors SLC34A2, SLC34A1, SLC20A1 MEN1 2248/4885KMT2A 4634/4885ALOX15 2311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.